ID   SCMC-MM-1
AC   CVCL_UF76
SY   MM-1
DR   JCRB; NIHS0045
DR   Wikidata; Q98129417
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=1313401;
RX   PubMed=23665679;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=1313401).
CC   Discontinued: JCRB; NIHS0045; true.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 6
//
RX   CelloPub=CLPUB00110;
RA   Hayashi Y., Hanada R., Moriwaki K., Yamamoto K., Imaizumi S.,
RA   Hirata A., Nishida T.;
RT   "Establishment and characterization of cell lines derived from
RT   malignant tumors in children.";
RL   Saitama Shoni Iryo Senta Igaku-shi 8:16-23(1991).
//
RX   DOI=10.2198/sbk.34.289;
RA   Mizusawa H.;
RT   "Operation of the JCRB cell bank and isoenzyme.";
RL   Seibutsu Butsuri Kagaku 34:289-292(1990).
//
RX   PubMed=1313401; DOI=10.1002/ijc.2910500626;
RA   Hosoi H., Sugimoto T., Hayashi Y., Inaba T., Horii Y., Morioka H.,
RA   Fushiki S., Hamazaki M., Sawada T.;
RT   "Differential expression of myogenic regulatory genes, MyoD1 and
RT   myogenin, in human rhabdomyosarcoma sublines.";
RL   Int. J. Cancer 50:977-983(1992).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//